Clinical trial

Reversing Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction

NCT06217120

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2024-03-01

PhasePHASE2 / PHASE3

Study timeline

Study start (estimated)2024-03-01Date precision: day

Registry last updated2024-01-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failure With Preserved Ejection Fractionunresolved

Microvascular Coronary Artery Diseaseunresolved

Interventions

ColchicineDRUG · verified · RxNorm: colchicine

PlaceboDRUG

Sponsors & collaborators

Montreal Heart Institutelead sponsor

Mapped research locations

MontrealQuebec, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06217120 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.